Zioptan is Now Available.

The U.S. Food and Drug Administration approved Zioptan (tafluprost ophthalmic solution), a new glaucoma medicine.

“Zioptan’s approval provides an alternative treatment option for patients living with this potentially blinding disease,” said Edward Cox, M.D., M.P.H, director of the Office of Antimicrobial Products in FDA’s Center for Drug Evaluation and Research.

Read the full press release here

Contact us to see if Zioptan is right for you.